Biostax Corp.

Biostax is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. Biostax has deep expertise and strong partnerships in the fields of autoimmunity and immune restoration and is able to deliver solutions today for people living with autoimmunity, chronic inflammation, infection, and cancer. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. Current efforts are focused in emerging markets where health challenges are prevalent, treatment expenses often limit availability for patients, and regulatory approval has already been granted. The company will also continue to pursue regulatory approval and commercialization initiatives in the U.S. and other international markets. Biostax intends to advance select and efficient small-scale biotechnology, pharmaceutical and MedTech programs through subsidiaries, investment vehicles and partnerships utilizing a biotech portfolio hub-and-spoke business model.